These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23300448)

  • 1. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
    PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
    PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
    Canavese M; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
    Zanini GM; Cabrales P; Barkho W; Frangos JA; Carvalho LJ
    J Neuroinflammation; 2011 Jun; 8():66. PubMed ID: 21649904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
    de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
    Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction.
    Reis PA; Alexandre PCB; D'Avila JC; Siqueira LD; Antunes B; Estato V; Tibiriça EV; Verdonk F; Sharshar T; Chrétien F; Castro-Faria-Neto HC; Bozza FA
    Brain Behav Immun; 2017 Feb; 60():293-303. PubMed ID: 27833044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
    Dai M; Freeman B; Shikani HJ; Bruno FP; Collado JE; Macias R; Reznik SE; Davies P; Spray DC; Tanowitz HB; Weiss LM; Desruisseaux MS
    PLoS One; 2012; 7(10):e44117. PubMed ID: 23082110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe malaria.
    Azevedo-Quintanilha IG; Vieira-de-Abreu A; Ferreira AC; Reis PA; Silva TI; Nascimento DO; Campbell RA; Estato V; Weyrich AS; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
    PLoS One; 2019; 14(12):e0224610. PubMed ID: 31869339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
    Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
    PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
    Weber C; Erl W; Weber KS; Weber PC
    J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
    Apoorv TS; Babu PP
    Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
    Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
    Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
    de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
    Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte Locomotion Inhibitory Factor confers neuroprotection and prevents the development of murine cerebral malaria.
    Galán-Salinas A; Corral-Ruíz G; Pérez-Vega MJ; Fabila-Castillo L; Silva-García R; Marquina-Castillo B; León-Contreras JC; Barrios-Payán J; Francisco-Cruz A; Montecillo-Aguado M; Huerta-Yepez S; Calderón-Amador J; Flores-Romo L; Hernández-Pando R; Sánchez-Torres LE
    Int Immunopharmacol; 2021 Aug; 97():107674. PubMed ID: 34044183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells protect against vascular damage and depression-like behavior in mice surviving cerebral malaria.
    Lima MN; Oliveira HA; Fagundes PM; Estato V; Silva AYO; Freitas RJRX; Passos BABR; Oliveira KS; Batista CN; Vallochi AL; Rocco PRM; Castro-Faria-Neto HC; Maron-Gutierrez T
    Stem Cell Res Ther; 2020 Aug; 11(1):367. PubMed ID: 32843073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain endothelial STING1 activation by
    Pais TF; Ali H; Moreira da Silva J; Duarte N; Neres R; Chhatbar C; Acúrcio RC; Guedes RC; Strano Moraes MC; Costa-Silva B; Kalinke U; Penha-Gonçalves C
    Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2206327119. PubMed ID: 36037380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA.
    Desruisseaux MS; Gulinello M; Smith DN; Lee SC; Tsuji M; Weiss LM; Spray DC; Tanowitz HB
    J Infect Dis; 2008 Jun; 197(11):1621-7. PubMed ID: 18419550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.